{"id":"https://openalex.org/W4400519934","doi":"https://doi.org/10.1016/j.clgc.2024.102154","title":"Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials","display_name":"Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials","publication_year":2024,"publication_date":"2024-07-11","ids":{"openalex":"https://openalex.org/W4400519934","doi":"https://doi.org/10.1016/j.clgc.2024.102154","pmid":"https://pubmed.ncbi.nlm.nih.gov/39094286"},"language":"en","primary_location":{"id":"doi:10.1016/j.clgc.2024.102154","doi":"https://doi.org/10.1016/j.clgc.2024.102154","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clgc.2024.102154","pdf_url":null,"source":{"id":"https://openalex.org/S71328803","display_name":"Clinical Genitourinary Cancer","issn_l":"1558-7673","issn":["1558-7673","1938-0682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Genitourinary Cancer","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108887100","display_name":"Isadora Mamede","orcid":"https://orcid.org/0009-0005-7154-8692","observed_orcids":["https://orcid.org/0009-0005-7154-8692"]},"institutions":[{"id":"https://openalex.org/I166595947","display_name":"Federal University of S\u00e3o Jo\u00e3o del-Rei","ror":"https://ror.org/03vrj4p82","country_code":"BR","type":"education","lineage":["https://openalex.org/I166595947"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Isadora Mamede","raw_affiliation_strings":["Department of Medicine, Federal University of Sao Joao del-Rei, Divinopolis, Minas Gerais 35501-296, Brazil. Electronic address: isamamede1@gmail.com"],"raw_orcid":"https://orcid.org/0009-0005-7154-8692","affiliations":[{"raw_affiliation_string":"Department of Medicine, Federal University of Sao Joao del-Rei, Divinopolis, Minas Gerais 35501-296, Brazil. Electronic address: isamamede1@gmail.com","institution_ids":["https://openalex.org/I166595947"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058371982","display_name":"Lorena Escalante\u2010Romero","orcid":"https://orcid.org/0009-0007-6583-3782","observed_orcids":["https://orcid.org/0009-0007-6583-3782"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Lorena Escalante-Romero","raw_affiliation_strings":["Department of Pediatric Oncology, Federal University of Sao Paulo, Sao Paulo, Sao Paulo 04021-001, Brazil"],"raw_orcid":"https://orcid.org/0009-0007-6583-3782","affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Federal University of Sao Paulo, Sao Paulo, Sao Paulo 04021-001, Brazil","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093760695","display_name":"Davi Said Gon\u00e7alves Celso","orcid":"https://orcid.org/0009-0008-0860-1747","observed_orcids":["https://orcid.org/0009-0008-0860-1747"]},"institutions":[{"id":"https://openalex.org/I146165071","display_name":"Universidade Federal de Vi\u00e7osa","ror":"https://ror.org/0409dgb37","country_code":"BR","type":"education","lineage":["https://openalex.org/I146165071"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Davi S. Gon\u00e7alves Celso","raw_affiliation_strings":["Department of Medicine, Federal University of Vicosa, Vicosa, Minas Gerais 36570-900, Brazil"],"raw_orcid":"https://orcid.org/0009-0008-0860-1747","affiliations":[{"raw_affiliation_string":"Department of Medicine, Federal University of Vicosa, Vicosa, Minas Gerais 36570-900, Brazil","institution_ids":["https://openalex.org/I146165071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101257058","display_name":"Pedro Cotta Abrah\u00e3o Reis","orcid":"https://orcid.org/0000-0001-8710-1784","observed_orcids":["https://orcid.org/0000-0001-8710-1784"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Pedro C. Abrahao Reis","raw_affiliation_strings":["Department of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Rio De Janeiro 21044-020, Brazil"],"raw_orcid":"https://orcid.org/0000-0001-8710-1784","affiliations":[{"raw_affiliation_string":"Department of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Rio De Janeiro 21044-020, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058225941","display_name":"Maria Inez Dacoregio","orcid":"https://orcid.org/0000-0003-0358-6652","observed_orcids":["https://orcid.org/0000-0003-0358-6652"]},"institutions":[{"id":"https://openalex.org/I4210133832","display_name":"Universidade Estadual do Centro-Oeste","ror":"https://ror.org/03cxsty68","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210133832"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Maria Inez Dacoregio","raw_affiliation_strings":["Department of Medicine, Universidade Estadual do Centro Oeste-UNICENTRO, Guarapuava, Parana 85015-430, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Universidade Estadual do Centro Oeste-UNICENTRO, Guarapuava, Parana 85015-430, Brazil","institution_ids":["https://openalex.org/I4210133832"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062478890","display_name":"Ana Caroline Fonseca Alves","orcid":"https://orcid.org/0009-0003-0274-2796","observed_orcids":["https://orcid.org/0009-0003-0274-2796"]},"institutions":[{"id":"https://openalex.org/I4210164671","display_name":"Hospital S\u00e3o Domingos","ror":"https://ror.org/05ng03c96","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210164671"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ana Caroline Alves","raw_affiliation_strings":["Department of Clinical Oncology, Sao Domingos Hospital/DASA, Sao Luis, Maranhao 65060-645, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Sao Domingos Hospital/DASA, Sao Luis, Maranhao 65060-645, Brazil","institution_ids":["https://openalex.org/I4210164671"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017195129","display_name":"Carlos Stecca","orcid":"https://orcid.org/0000-0001-9103-9119","observed_orcids":["https://orcid.org/0000-0001-9103-9119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos Stecca","raw_affiliation_strings":["Department of Clinical Oncology, Mackenzie Evangelical University Hospital, Curitiba, Parana 80730-150, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Mackenzie Evangelical University Hospital, Curitiba, Parana 80730-150, Brazil","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5108887100"],"corresponding_institution_ids":["https://openalex.org/I166595947"],"apc_list":{"value":3690,"currency":"USD","value_usd":3690},"apc_paid":null,"fwci":0.5905,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.51307805,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"22","issue":"5","first_page":"102154","last_page":"102154"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-urothelial-carcinoma","display_name":"advanced urothelial carcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8399999737739563},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9589999914169312},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.7770000100135803},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/enfortumab-vedotin","display_name":"enfortumab vedotin","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9290000200271606},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9739999771118164},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9067433476448059},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8406456708908081},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7678700685501099},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7055265307426453},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6126804351806641},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.6084166169166565},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5983225107192993},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5511583089828491},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.45014551281929016},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.44712314009666443},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4128724932670593},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.41084975004196167},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35941511392593384}],"mesh":[{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D014571","descriptor_name":"Urologic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014571","descriptor_name":"Urologic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014571","descriptor_name":"Urologic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D014571","descriptor_name":"Urologic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clgc.2024.102154","doi":"https://doi.org/10.1016/j.clgc.2024.102154","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clgc.2024.102154","pdf_url":null,"source":{"id":"https://openalex.org/S71328803","display_name":"Clinical Genitourinary Cancer","issn_l":"1558-7673","issn":["1558-7673","1938-0682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Genitourinary Cancer","raw_type":"journal-article"},{"id":"pmid:39094286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39094286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical genitourinary cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1999130958","https://openalex.org/W2019607817","https://openalex.org/W2033987156","https://openalex.org/W2097995306","https://openalex.org/W2120955645","https://openalex.org/W2567362164","https://openalex.org/W2783137027","https://openalex.org/W2786816161","https://openalex.org/W2970684805","https://openalex.org/W3024551702","https://openalex.org/W3087464965","https://openalex.org/W3087466624","https://openalex.org/W3088592859","https://openalex.org/W3118615836","https://openalex.org/W3163995648","https://openalex.org/W3164197656","https://openalex.org/W3200450511","https://openalex.org/W3210474759","https://openalex.org/W4200026971","https://openalex.org/W4205423844","https://openalex.org/W4206159727","https://openalex.org/W4304175291","https://openalex.org/W4324136624","https://openalex.org/W4378232556","https://openalex.org/W4387859553","https://openalex.org/W4389606368","https://openalex.org/W4392498919","https://openalex.org/W4392769651","https://openalex.org/W4399393969"],"related_works":["https://openalex.org/W4399394262","https://openalex.org/W4401975188","https://openalex.org/W4312987815","https://openalex.org/W4407055347","https://openalex.org/W4390533796","https://openalex.org/W4211025551","https://openalex.org/W4392575552","https://openalex.org/W7163648968","https://openalex.org/W4380290766","https://openalex.org/W4400201911"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-12T00:00:00"}